SLC6A3 and Parkinson disease: DAT imaging with single‐photon emission computerized tomography (SPECT) is being used as an in vivo biomarker of nigrostriatal neuron loss in PD, and the overall striatal DAT binding correlates well with the Hoehn and Yahr stage (Pirker, 2003).